Deutsche Märkte geschlossen

Biomerica, Inc. (BMRA)

NasdaqCM - NasdaqCM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
0,6930+0,0130 (+1,91%)
Ab 03:19PM EDT. Markt geöffnet.

Biomerica, Inc.

17571 Von Karman Avenue
Irvine, CA 92614
United States
(949) 645-2111
https://www.biomerica.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter62

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Zackary S. IraniChief Executive Officer141,25kN/A1966
Mr. Allen C. BarbieriExecutive Vice-Chairman of the Board & Corporate Secretary126,25kN/A1958
Mr. Gary Lu CPAPrincipal Accounting Officer & CFO260kN/A1981
Ms. Lucy Liu Ph.D.Director of Manufacturing & Technical OperationsN/AN/AN/A
Mr. Robert W. CarlsonChief Commercial OfficerN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Corporate Governance

Biomerica, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.